According to new data from Hirsch et al., the risk of polyomavirus BK (BKV) viraemia in kidney transplant recipients is increased by high steroid exposure early after transplantation, treatment with tacrolimus rather than ciclosporin A, older donor age and male gender. However, confounding of results due to variations in immunosuppressive drug exposure cannot be excluded.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schold, J. D. et al. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl. Int. 22, 626–634 (2009).
Bohl, D. L. et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am. J. Transplant. 5, 2213–2221 (2005).
Hirsch, H. H. et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cysclosporine: a prospective, randomized, multicenter study. Am. J. Transplant. http://dx.doi.org/10.1111/j.1600-61432012.04320.x.
Binet, I. et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 67, 918–922 (1999).
Manitpisitkul, W. et al. Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation 88, 83–88 (2009).
Hardinger, K. L., Koch, M. J., Bohl, D. J., Storch, G. A. & Brennan, D. C. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am. J. Transplant. 10, 409–415 (2010).
Anglicheau, D. et al. Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation. Nephrol. Dial. Transplant. 18, 2409–2414 (2003).
Vincenti, F. et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am. J. Transplant. 7, 1506–1514 (2007).
Acott, P. D., O'Regan, P. A., Lee, H. S. & Crocker, J. F. In vitro effect of cyclosporine A on primary and chronic BK polyoma virus infection in Vero E6 cells. Transpl. Infect. Dis. 10, 385–390 (2008).
Pham, P.-T., Schaenman, J. & Pham, P. C. BK virus screening and management following kidney transplantation: an update. J. Transplant. Technol. Res. 2, e119 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Pham, PT., Reddy, U. Immunosuppression and risk of polyomavirus BK replication. Nat Rev Nephrol 9, 135–136 (2013). https://doi.org/10.1038/nrneph.2013.17
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.17
